As the PI3K-AKT pathway is known to regulate cell proliferation, cell death and motility to facilitate cancer development in various cancers19,20,25, our results indicate that PI3K might be a potential downstream target of RAD21 in NSCLC. The gene discussed is AKT1; the disease is cancer.